Records containing: Monoclonal Gammopathy of Undetermined Significance (MGUS)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
-
CLINICAL_TRIALS study record update · 2026-04-08Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-02-12Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and Clinical Outcome
-
CLINICAL_TRIALS study record update · 2026-01-20CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
-
CLINICAL_TRIALS study record update · 2025-12-19A Pilot Study of 13Carbon-Based Deep Labeling of Bone Marrow Cells to Map Their Utilization of Extracellular Metabolites
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-19The Development and Pilot Testing of a New Magnetic Resonance (MR) Imaging Protocol to Quantify Both Myeloma Disease Burden and Associated Bone Loss
-
CLINICAL_TRIALS study record update · 2024-12-27Gut Microbiota Profiling in Patients With Monoclonal Gammopathy: Implications for Disease Pathogenesis and Progression
-
CLINICAL_TRIALS study record update · 2022-04-25A Prospective Cohort Study of Patients With Plasma Cell Disorders (PCDs) in PKUFH